Is Allulose Sweetener Safe to Use in Canada?
What’s happening?
Information about allulose
Recent related evidence
A systematic review and meta-analysis reviewed eight studies that looked at allulose’s effects on blood glucose concentrations in healthy adults after consuming a meal with and without allulose (7). All the studies were small (eight to 30 individuals per group), randomized and single or double blinded. Liquid or solid allulose was used in doses between 5 and 10 grams per meal. The authors found that in healthy adults, 5 or 10 g of allulose added to a meal was effective in lowering blood glucose levels as compared to control groups without allulose taken at a meal. The study did not report adverse effects.
A prospective, single-blind, randomized crossover study involving 24 people (20 to 80 years) with type 2 diabetes in the hospital compared peak postprandial blood glucose levels after the consumption of a standard hospital diabetic diet and the same diet but containing 8.5 g of D-allulose per meal (8). Over five days, the participants followed each type of diet for two consecutive days (3 meals/day), each with a washout period between diets of at least one day. Blood glucose levels were measured using continuous glucose monitoring. The authors found that for the participants who consumed the diabetic diet containing allulose, their postprandial blood glucose levels were significantly lower compared to the participants who consumed a normal diabetic diet free from allulose. No diarrhea or safety concerns were identified. In contrast, another small, randomized crossover study in 16 individuals with diabetes found no effect on glycemic response after 12 weeks of allulose (7 g, twice daily) compared to aspartame (0.3 g, twice daily) (9).
The bottom line
- education and guidance on energy allowance when incorporating sweeteners within a healthy eating pattern
- instruction on how to read product labels and how to use the information when carbohydrate counting and adjusting insulin levels
- information on safety and potential adverse effects, including gastrointestinal effects if consuming a lot of sweetener at one time.
- Sweetener Knowledge Pathway
- What effect do sweeteners (e.g. nonnutritive, artificial, intense, low calorie, sugar substitutes) have on the management of diabetes?
- Sweetener Summary of Recommendations and Evidence
- Sweetener Background.
References
- Food and Drug Administration (FDA). The declaration of allulose and calories from allulose on nutrition and supplement facts labels: guidance for industry. 2020 Oct. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-declaration-allulose-and-calories-allulose-nutrition-and-supplement-facts-labels
- Schwarcz J. The allure of allulose. McGill University. Office for Science and Society. 2022 Mar. Available from: https://www.mcgill.ca/oss/article/health-and-nutrition/allure-allulose#:~:text=Allulose%20has%20not%20been%20approved,can%20be%20sold%20in%20Canada.
- Southey F. Allulose approval in Europe to be sought by new ingredients consortium. Food Navigator Europe. 2021 Dec. Available from: https://www.foodnavigator.com/Article/2021/12/07/Allulose-approval-in-Europe-to-be-sought-by-new-ingredients-consortium
- Food Standards Australia New Zealand (FSANZ). Call for comment on D-allulose as a novel food. 2023 Dec. Available from: https://www.foodstandards.gov.au/media/d-allulose-novel-food
- Regulations.gov. Reference 8- FDA memo to the file_scientific review for allulose re: the declaration of allulose and calories from allulose on nutrition and supplement facts labels: guidance for industry draft guidance. 2019 Apr. Available from: https://www.regulations.gov/document/FDA-2019-D-0725-0012
- Sollid K. Up close on allulose labelling. Food Insight. 2022 Jan. Available from: https://foodinsight.org/allulose-labeling/
- Yuma T, Tokuda M, Nishimoto N, Yokoi H, Izumori K. Allulose for the attenuation of postprandial blood glucose levels in healthy humans: A systematic review and meta-analysis. PLoS One. 2023 Apr 6;18(4):e0281150. doi: 10.1371/journal.pone.0281150. eCollection 2023. Abstract available from: https://pubmed.ncbi.nlm.nih.gov/37023000/
- Fukunaga K, Yoshimura T, Imachi H, Kobayashi T, Saheki T, Sato S, Saheki N, Jiang W, Murao K. A pilot study on the efficacy of a diabetic diet containing the rare sugar d-allulose in patients with type 2 diabetes mellitus: a prospective, randomized, single-blind, crossover study. Nutrients. 2023;15(12). doi: 10.3390/nu15122802. Abstract available from: https://pubmed.ncbi.nlm.nih.gov/37375710/
- Preechasuk L, Luksameejaroenchai C, Tangjittipokin W, Kunavisarut T. Short-term effects of allulose consumption on glucose homeostasis, metabolic parameters, incretin levels, and inflammatory markers in patients with type 2 diabetes: a double-blind, randomized, controlled crossover clinical trial. Eur J Nutr. 2023 Oct;62(7):2939-2948. doi: 10.1007/s00394-023-03205-w. Epub 2023 Jul 11. PMID: 37432472. Abstract available from: https://pubmed.ncbi.nlm.nih.gov/37432472/